Ascendis Health lists on the JSE’s Main Board

November 23, 2013


Johannesburg, 22 November 2013 – Today Ascendis Health Limited (JSE: ASC) listed on the JSE’s Main Board becoming the 8th health sector company to list on the JSE’s Main Board.

Ascendis Health is a health and care brands company operating in plant & animal and human health which makes an approximate annual turnover of R2 billion. As one part of its growth strategy Ascendis also has a strong focus on acquisitive growth utilising the private equity deal team of its controlling shareholder Coast2Coast.

CEO of Ascendis Health, Karsten Wellner says: "We are very excited about the JSE offering us this opportunity to raise our public profile. The listing will give us access to new equity capital to fund our acquisitive and organic growth strategies, broaden our capital base as well as raise our accountability and profile internally and externally. It is also important for us to create a track record and trust with our investors, customers and employees. Many customers in South Africa are familiar with our brands and have been for years - Ascendis Health is making these brands even stronger. The JSE will assist us in achieving these goals and also afford us the ability to internationalise this great company into a globally integrated Health and Care company."

“We are delighted to welcome Ascendis Health to the main board of the JSE and wish CEO Karsten Wellner and his team every success. This listing will provide both local and international investors with investment options in the sector,” says Zeona Jacobs, Director of Issuer and Investor Relations at the JSE.

For more information about Ascendis Health please visit 
For media enquiries regarding Ascendis Health please contact:
Jeremy Nel
Luxury Brands
Tel: +27823311656

About JSE Limited
As South Africa’s only full service securities exchange, the JSE connects buyers and sellers in five different financial markets, namely equities, equity derivatives, commodity derivatives, currency derivatives and interest rate products. The JSE Ltd offers the investor a truly first world trading environment, with world class technology, surveillance and settlement in an emerging market context. It is amongst the top 20 largest equities exchanges in terms of market capitalisation in the world. In terms of derivatives, the JSE is currently ranked the 20th largest exchange by the Futures Industry Association (FIA).
For further information, please visit  

Victoria Williams
H+K Strategies
Tel: +27 11 463 2198

Zeona Jacobs
Director Issuer and Investor Relations